High Net Worth Advisory Group’s Sanofi SNY Stock Holding History

High Net Worth Advisory Group’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-376	Closed	-$14K	–	687
2022 Q3	$14K	Hold	376	–	–	0.01%	497
2022 Q2	$19K	Hold	376	–	–	0.01%	462
2022 Q1	$19K	Hold	376	–	–	0.01%	461
2021 Q4	$19K	Buy	+376	New	+$18.6K	0.01%	470

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

High Net Worth Advisory Group's SNY Position: Q4 2022 in Review

High Net Worth Advisory Group sold out of Sanofi (SNY) in Q4 2022, closing a stake of 376 shares — an estimated $14K sold.

High Net Worth Advisory Group first reported a position in SNY in Q4 2021 and held it in 4 quarters. The position peaked at $19K in Q2 2022. 643 funds tracked by Wall St. Rank hold SNY as of Q4 2022.

High Net Worth Advisory Group reported no remaining Sanofi position as of Q4 2022 after selling out during the quarter.
High Net Worth Advisory Group sold 376 Sanofi shares in Q4 2022, an estimated $14K.
High Net Worth Advisory Group first reported a position in Sanofi in Q4 2021 and held it in 4 quarters.
High Net Worth Advisory Group's Sanofi position peaked at $19K in Q2 2022.
643 funds tracked by Wall St. Rank held Sanofi as of Q4 2022.

Based on High Net Worth Advisory Group's 13F filing for Q4 2022, filed 14 Feb 2023.